Biote Corp Class A (BTMD) financials

NASDAQ · Health Care

$1.11 -5.13% Close Oct 30, 2026 Live

Biote revenue and earnings by year

Biote's revenue was $192 million in the fiscal year to December 31, 2025, down 2.5% from the year before. Net income was $27.0 million, 14.1% of revenue. Since the fiscal year to December 31, 2019, revenue has grown 9.8% a year on average.

RevenueNet income
$0$100M$200M
2019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 7 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Revenue192197185165139117110
Revenue growth-2.5%6.4%12.4%18.3%19.6%6.0%—
Gross profit137139127110917266
Gross margin71.5%70.5%68.8%66.9%65.0%61.5%60.4%
Operating income363229-61353224
Operating margin18.5%16.0%15.5%-36.8%24.8%27.3%21.4%
Net income2733-1332921
Net margin14.1%1.6%1.8%-0.6%23.4%25.0%19.4%
Diluted EPS$0.74$0.09$0.13————
Free cash flow283824-11302524

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open BTMD in Markets.

How Biote makes money

Revenue by segment in the quarter to June 30, 2026, as the company reports it.

SegmentRevenueShare
Pellet Procedures Product Revenue$30.3M68.5%
Dietary Supplements$11.4M25.7%
Disposable Trocars Product Revenue$1.21M2.7%
Shipping Fees & Other Product Revenue$505K1.1%
Other Service Revenue$406K0.9%
Contract Term Services Revenue$311K0.7%
Training Service Revenue$134K0.3%

See also: BTMD valuation and P/E history · BTMD returns

No forecast, no recommendation. This page describes Biote Corp Class A from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.